PHARMAC is seeking feedback
on a proposal relating to the
funding of the TNF-inhibitor
medicines adalimumab (Humira)
and etanercept (Enbrel), both
used to treat people with various
autoimmune and immunemediated
gabapentin (Neurontin), used to
treat epilepsy & neuropathic pain.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 15 Jul 15 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Jul 15
TWO in five insulin injection users have never been shown the correct needle size or the need to rotate the injection site, according to new data published from a survey conducted by the RACGP’s Diabetes Specific Interest Network, reported in 6minutes.
VETERAN Salvation Army suicide prevention campaigner 86 year old Alan Staines OAM has yesterday completed his walk from Canberra to Sydney promoting the message that we need more services for those bereaved by suicide.